100 – What is the most optimal VTE prophylaxis following TKA/THA? https://icmphilly.com/?page_id=11296
102 – Is there a difference in VTE risk profile for patients undergoing total hip arthroplasty or total knee arthroplasty? https://icmphilly.com/?page_id=11282
103 – Should mechanical compressive devices be used routinely in patients undergoing total hip arthroplasty or total knee arthroplasty? https://icmphilly.com/?page_id=10433
104 – Should pneumatic compression devices (PCD) routinely be co-administered to patients receiving aspirin for VTE prophylaxis? https://icmphilly.com/?page_id=11287
105 – Considering the trend to ambulatory hip and knee arthroplasty, is there a role for the use of pneumatic compression devices? https://icmphilly.com/?page_id=10429
106 – What is the chemoprophylactic agent of choice for patients undergoing simultaneous bilateral total hip arthroplasty (SBTHA)? https://icmphilly.com/?page_id=10346
107 – What is the chemoprophylactic agent of choice for patients undergoing simultaneous bilateral total knee arthroplasty (SBTKA)? https://icmphilly.com/?page_id=10340
108 – Do patients undergoing UKA, including patellofemoral joint arthroplasty, have a different VTE risk profile compared to TKA? https://icmphilly.com/?page_id=10723
109 – Does the “enhanced recovery” concept, which includes early ambulation, reduce the risk of VTE in patients undergoing primary total hip or knee arthroplasty? https://icmphilly.com/?page_id=11278
110 – Does the use of Continuous Passive Machine (CPM) reduce the risk of VTE following knee surgery? https://icmphilly.com/?page_id=11274
111 – Should the use of lower extremity tourniquet be avoided in patients at a high risk of VTE? https://icmphilly.com/?page_id=10316
112 – Is VTE after elective total joint arthroplasty a “never event”? https://icmphilly.com/?page_id=11267
113 – What is the optimal choice for VTE prophylaxis following two-stage or resection arthroplasty for treatment of knee and hip periprosthetic joint infection? https://icmphilly.com/?page_id=11263
114 – Should the method for VTE prophylaxis be altered in patients undergoing revision for infection? https://icmphilly.com/?page_id=11304
115 – Do patients undergoing elective pelvic and/or femoral osteotomy require routine VTE prophylaxis? https://icmphilly.com/?page_id=10441
116 – What are the indications for Doppler ultrasound of the lower extremity to confirm or rule out DVT? https://icmphilly.com/?page_id=10636
117 – Should the presence of a distal DVT in an extremity mandate repeat imaging of proximal veins? https://icmphilly.com/?page_id=10225
118 -What is the incidence of readmission and re-operation for hematomas secondary to administration of chemoprophylaxis for VTE in patients undergoing total joint arthroplasty? https://icmphilly.com/?page_id=11300
119 – Which VTE prophylactic agent used in patients undergoing TKA/THA has the highest bleeding rate? https://icmphilly.com/?page_id=10463
120 – Does the type of VTE prophylaxis influence the risk of subsequent periprosthetic joint infection in patients undergoing joint arthroplasty? https://icmphilly.com/?page_id=11239
121 – Does the type of VTE prophylaxis influence the risk of subsequent surgical site infection (SSI) in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=11233